These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Recurrent cytogenetic aberrations in human ovarian carcinomas. Kiechle-Schwarz M; Bauknecht T; Schmidt J; Walz L; Pfleiderer A Cancer Detect Prev; 1995; 19(3):234-43. PubMed ID: 7750111 [TBL] [Abstract][Full Text] [Related]
8. Cytogenetic observations on two ovarian carcinomas with double minutes, one with a 6q- marker chromosome. Bullerdiek J; Bartnitzke S; Kahrs E; Schloot W Cytobios; 1985; 42(165):15-24. PubMed ID: 3858061 [TBL] [Abstract][Full Text] [Related]
9. Frequent PTEN/MMAC mutations in endometrioid but not serous or mucinous epithelial ovarian tumors. Obata K; Morland SJ; Watson RH; Hitchcock A; Chenevix-Trench G; Thomas EJ; Campbell IG Cancer Res; 1998 May; 58(10):2095-7. PubMed ID: 9605750 [TBL] [Abstract][Full Text] [Related]
10. Interphase cytogenetic analysis of serous ovarian tumors of low malignant potential: comparison with serous cystadenomas and invasive serous carcinomas. Diebold J; Deisenhofer I; Baretton GB; Blasenbreu S; Suchy B; Schneiderbanger K; Meier W; Haas CJ; Löhrs U Lab Invest; 1996 Oct; 75(4):473-85. PubMed ID: 8874380 [TBL] [Abstract][Full Text] [Related]
11. Should All Cases of High-Grade Serous Ovarian, Tubal, and Primary Peritoneal Carcinomas Be Reclassified as Tubo-Ovarian Serous Carcinoma? Moss EL; Evans T; Pearmain P; Askew S; Singh K; Chan KK; Ganesan R; Hirschowitz L Int J Gynecol Cancer; 2015 Sep; 25(7):1201-7. PubMed ID: 26035124 [TBL] [Abstract][Full Text] [Related]
12. Karyotypic characterization of bronchial large cell carcinomas. Johansson M; Dietrich C; Mandahl N; Hambraeus G; Johansson L; Clausen PP; Mitelman F; Heim S Int J Cancer; 1994 May; 57(4):463-7. PubMed ID: 8181850 [TBL] [Abstract][Full Text] [Related]
13. Interphase fluorescence in situ hybridization studies of ovarian adenocarcinomas using the midisatellite probe. Kalir T; Eisberg A; Dottino P; Cohen C Gynecol Oncol; 1999 Feb; 72(2):208-14. PubMed ID: 10021303 [TBL] [Abstract][Full Text] [Related]
14. Involvement of DPP9 in gene fusions in serous ovarian carcinoma. Smebye ML; Agostini A; Johannessen B; Thorsen J; Davidson B; Tropé CG; Heim S; Skotheim RI; Micci F BMC Cancer; 2017 Sep; 17(1):642. PubMed ID: 28893231 [TBL] [Abstract][Full Text] [Related]
16. Aberrant Expression of Anaplastic Lymphoma Kinase in Ovarian Carcinoma Independent of Gene Rearrangement. Tang S; Yang F; Du X; Lu Y; Zhang L; Zhou X Int J Gynecol Pathol; 2016 Jul; 35(4):337-47. PubMed ID: 27271776 [TBL] [Abstract][Full Text] [Related]
17. beta-catenin expression pattern in stage I and II ovarian carcinomas : relationship with beta-catenin gene mutations, clinicopathological features, and clinical outcome. Gamallo C; Palacios J; Moreno G; Calvo de Mora J; Suárez A; Armas A Am J Pathol; 1999 Aug; 155(2):527-36. PubMed ID: 10433945 [TBL] [Abstract][Full Text] [Related]
18. Sox10 expression in ovarian epithelial tumors is associated with poor overall survival. Kwon AY; Heo I; Lee HJ; Kim G; Kang H; Heo JH; Kim TH; An HJ Virchows Arch; 2016 May; 468(5):597-605. PubMed ID: 26951260 [TBL] [Abstract][Full Text] [Related]
19. Chromosomal imbalance maps of malignant solid tumors: a cytogenetic survey of 3185 neoplasms. Mertens F; Johansson B; Höglund M; Mitelman F Cancer Res; 1997 Jul; 57(13):2765-80. PubMed ID: 9205089 [TBL] [Abstract][Full Text] [Related]
20. Identification of allelic losses in benign, borderline, and invasive epithelial ovarian tumors and correlation with clinical outcome. Saretzki G; Hoffmann U; Röhlke P; Psille R; Gaigal T; Keller G; Höfler H; Löning T; Petersen I; Dietel M Cancer; 1997 Oct; 80(7):1241-9. PubMed ID: 9317174 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]